Indian firms anticipate limited gains from generic Effexor XR launch
This article was originally published in Scrip
Executive Summary
Orchid Chemicals & Pharmaceuticals has joined a growing list of firms that include the Indian companies, Lupin and Aurobindo, which are gearing for a US launch of generic versions of Pfizer's extended-release venlafaxine product, Effexor XR capsules, in June, following settlements with the originator.